Package Leaflet: Information for the User
Hydroxychloroquine Aristo200 mg film-coated tablets EFG
Hydroxychloroquine sulfate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
Each film-coated tablet of Hydroxychloroquine Aristo contains the active substance hydroxychloroquine sulfate.
Hydroxychloroquine Aristo is used in adults for:
Hydroxychloroquine Aristo is used in children ≥ 6 years (≥ 35 kg) for:
Do not takeHydroxychloroquine Aristoif:
Warnings and precautions
Talk to your doctor or pharmacist before you start taking Hydroxychloroquine Aristo
Before you start taking this medicine, your doctor will examine your eyes to determine if there are any abnormalities. This eye examination should be repeated with prolonged use of this medicine. If you experience problems while using this medicine (for example, if you notice a reduction in visual acuity, color quality, or a reduction in your field of vision), contact your doctor immediately. Concomitant use with medicines known to be harmful to the retina (such as tamoxifen) is not recommended.
Hydroxychloroquine may cause heart rhythm disorders in some patients. Caution should be exercised when using hydroxychloroquine
When using hydroxychloroquine, you should protect yourself from direct sunlight.
Severe cutaneous adverse reactions (SCARs)
During treatment with hydroxychloroquine, cases of severe cutaneous adverse reactions have been reported (see section 4 “Possible side effects”). Often, the rash can involve ulcers in the mouth, throat, nose, genitals, and conjunctivitis (red and swollen eyes). These severe skin rashes are usually preceded by symptoms similar to those of the flu, such as fever, headache, and body aches. The rash can progress to form generalized blisters and skin peeling. If you develop these skin symptoms, stop taking hydroxychloroquine and contact your doctor.
Hepatotoxicity
During the use of hydroxychloroquine, cases of severe drug-induced liver injury (DILI) have been reported, including hepatocellular injury, cholestatic liver injury, acute hepatitis, mixed hepatocellular/cholestatic liver injury, and fulminant liver failure (including fatal cases).
Risk factors may include pre-existing liver disease or predisposing conditions such as uroporphyrinogen decarboxylase deficiency or concomitant hepatotoxic medications.
If you experience symptoms that may indicate liver damage, your doctor will perform tests to evaluate liver function. If you have significant liver function abnormalities, your doctor will decide whether to discontinue treatment with hydroxychloroquine.
Cardiac arrhythmia
If you experience palpitations or irregular heartbeats during the treatment period, you should inform your doctor immediately. The risk of heart problems may increase with increasing dose. Therefore, the recommended dose should be followed.
Additionally, heart failure has been observed after the use of this medicine, in some cases with a fatal outcome. Symptoms of heart failure include fatigue, difficulty breathing, and swelling of the legs and ankles. Contact your doctor if these symptoms occur.
Drug-induced phospholipidosis
Cases of drug-induced phospholipidosis have been reported during the use of hydroxychloroquine. Drug-induced phospholipidosis can occur in several organ systems, such as the heart, kidneys, or muscles. Monitoring for toxicity is recommended. If phospholipidosis is suspected or confirmed by tissue biopsy, your doctor will decide whether to discontinue treatment with hydroxychloroquine.
Low blood sugar
This medicine may cause a severe decrease in blood sugar levels (hypoglycemia). If you notice any of the following symptoms (sweating, trembling, dizziness, irritability, headache, fatigue, hunger) or loss of consciousness, contact your doctor to check your blood sugar levels.
Long-term therapy controls
A complete blood count should be performed before starting long-term treatment and at intervals of 2 months. If changes occur in the blood count, your doctor will decide whether to discontinue treatment with hydroxychloroquine.
If you use this medicine for a prolonged period, your muscle and tendon function should be periodically monitored. If you suffer from weak muscles or tendons, consult your doctor. The doctor may decide to discontinue treatment.
Movement disorders
Movement disorders (extrapyramidal symptoms) may occur (see section 4 “Possible side effects”) when using this medicine.
Self-destructive behavior and mental health problems
Some people treated with hydroxychloroquine may experience mental health problems, such as irrational thoughts, anxiety, hallucinations, a feeling of confusion, or depression, including thoughts of self-harm or suicide. This also applies to people who have never had similar problems before. If you or others around you notice any of these side effects (see section 4), seek medical attention immediately and stop taking hydroxychloroquine if you have thoughts of self-harm or suicide.
Children
Keep the product out of the sight and reach of children. Young children are particularly sensitive to the potential harmful effects of this medicine.
Other medicines and Hydroxychloroquine Aristo
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This includes, in particular:
TakingHydroxychloroquine Aristowith food and drink
Avoid drinking grapefruit juice as it may increase the risk of side effects. Avoid drinking large amounts of alcohol.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your doctor will discuss with you whether hydroxychloroquine is suitable for you.
Hydroxychloroquine may be associated with a small increased risk of major birth defects and should not be used during pregnancy unless your doctor considers that the benefits outweigh the risks.
Malaria prevention and treatment.
If your doctor considers that the benefits outweigh the risks, hydroxychloroquine may be used for the prophylaxis and treatment of malaria infections, as the malaria infection itself is harmful to the fetus.
Breastfeeding
This medicine is excreted in breast milk. It is known that young children are very sensitive to the side effects of this medicine.
Malaria prevention and treatment
Hydroxychloroquine should not be used during breastfeeding unless your doctor considers that the benefits outweigh the risks.
You do not need to stop breastfeeding if you use this medicine for malaria prevention. However, the amount of hydroxychloroquine that reaches the infant through breast milk is insufficient to prevent malaria in the infant.
Rheumatoid arthritis and lupus erythematosus
When this medicine is used in high doses for a prolonged period, breastfeeding should be interrupted.
Contraception
During treatment and at least 3 months after stopping treatment, pregnancy should be avoided. Hydroxychloroquine should not be used during breastfeeding unless your doctor considers that the benefits outweigh the risks.
Ask your doctor or pharmacist for advice before taking any medicine if you are pregnant or breastfeeding. Your doctor will discuss with you whether hydroxychloroquine is suitable for you.
Fertility
There is no information on the effects of hydroxychloroquine on fertility in humans.
Driving and using machines
You may experience eye problems and dizziness while taking this medicine. If this happens, do not drive or use tools or machines and inform your doctor immediately.
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
How Much to Take
The recommended dose is:
For Adults
Rheumatoid Arthritis
Initial dose: 400 mg per day, in a single dose or divided into two doses once a day.
Maintenance dose: 200 mg per day, possibly 200 mg every other day thereafter.
Systemic Lupus Erythematosus and Discoid
Initial dose: 400 mg (as a single dose or divided into two doses) to 600 mg (as a single dose or divided into two or three doses) per day.
Maintenance dose: 200 mg to 400 mg (as a single dose or divided into two doses) per day.
Malaria Prevention
Adults: 400 mg per week on the same day every week. In malaria prevention, you should receive treatment for one week before arriving in the malaria area and continue it for four weeks after leaving that area.
Treatment of an Acute Malaria Attack
The dose in case of an acute malaria attack depends on the nature of the infection. The total dose is up to 2 grams and is administered over a maximum of three days.
For Children
Your doctor will determine the dose based on body weight. The 200 mg tablet is not suitable for children with a body weight of less than 35 kg.
Renal and Hepatic Insufficiency
If you have renal or hepatic insufficiency, your doctor may prescribe a lower dose.
Duration of Treatment
Follow your doctor's instructions regarding the duration of treatment. Your doctor will give you the lowest possible dose for long-term treatment with this medication. In the treatment of joint disorders, this medication needs several weeks to achieve its best effect.
Taking this Medication
Method of Administration
The film-coated tablets should be taken without chewing, with food or with a glass of milk. It is possible to experience a bad taste when taking this product.
If You Take MoreHydroxychloroquine AristoThan You Should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Phone 91 562 04 20, indicating the medication and the amount ingested.
If You Miss a Dose ofHydroxychloroquine Aristo
If you miss a dose of hydroxychloroquine, you can take it as soon as you remember, unless it is almost time for your next dose, in which case you should continue with your medication as prescribed. Do not take a double dose to make up for a missed tablet. If you have missed more than one dose, contact your doctor or pharmacist.
If You Interrupt Treatment withHydroxychloroquine Aristo
Continue taking your medication until your doctor tells you to stop. Do not stop taking hydroxychloroquine just because you feel better. If you do, your illness may worsen again.
If you have any other questions about this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Stop Taking Hydroxychloroquine Aristo and Go to a Doctor Immediately if You Notice Any of the Following Side Effects:
Rare side effects (may affect up to 1 in 1,000 people)
Frequency not known (cannot be estimated from the available data)
Other side effects associated with hydroxychloroquine sulfate
Frequent side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Frequency not known (cannot be estimated from the available data)
Reporting Side Effects
If you experience any side effects, consult your doctor, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use Hydroxychloroquine Aristo after the expiration date stated on the packaging, after EXP. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from light.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medication in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition ofHydroxychloroquine Aristo
Appearance of the Product and Package Contents
Hydroxychloroquine Aristo 200 mg film-coated tablets are white, circular, and biconvex, film-coated, marked with "200" on one side and smooth on the other. Hydroxychloroquine Aristo 200 mg film-coated tablets are presented in PVC/aluminum blisters. Packs of 30 and 100 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder and Responsible for Marketing
Aristo Pharma GmbH
Wallenroder Straße 8-10
13435 Berlin
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
This medication is authorized in the Member States of the European Economic Area under the following names:
Germany: Hydroxychloroquine Aristo 200 mg film-coated tablets
Spain: Hydroxychloroquine Aristo 200 mg film-coated tablets EFG
Date of the Last Revision of this Leaflet:June 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://aemps.gob.es/